POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler
Clinical trial NCT01051817 · COMPLETED
Trial details
- NCT number
- NCT01051817
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2012-04-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.